Repurposing Metformin as a Leukemia-preventive Drug in CCUS and LR-MDS
Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
This is a phase 2 single-arm pilot study of the efficacy and safety of metformin in patients
with clonal cytopenia of undetermined significance (CCUS) or lower-risk myelodysplastic
syndrome (MDS).
Phase:
Phase 2
Details
Lead Sponsor:
Kirsten Grønbæk
Collaborators:
Herlev Hospital Region Hovedstadens Apotek Rigshospitalet, Denmark Steno Diabetes Center Copenhagen Technical University of Denmark University of Copenhagen Van Andel Research Institute Zealand University Hospital